ESC 365 - Cardioprotective potential of exosomes derived from blood outgrowth endothelial cells in ischemic cardiomyopathy

ESC Professional Premium Access

Cardioprotective potential of exosomes derived from blood outgrowth endothelial cells in ischemic cardiomyopathy

Session: Drug-related risk management in chronic coronary syndromes

Topic: Pharmacotherapy

Speaker: Doctor M. Wu (Leuven, BE)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Ming Wu

KU Leuven, Leuven (Belgium)

0 follower

6 more presentations in this session

Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study

Speaker: Doctor J. Shanmuganathan (Aalborg, DK)

Non-clinical evaluation of YN001-a promising drug for atherosclerotic therapy by targeted delivery system

Speaker: Doctor Q. Ma (Beijing, CN)

Combination of nicorandil and beta-adrenergic receptor blockers in patients with coronary heart disease: a real-world observational study

Speaker: Professor N. Zhou (Wuhan, CN)

PSRC1 rs599839 G allele may promote protection from coronary artery disease in a Madeira Island population

Speaker: Mr F. Sousa (Funchal, PT)

Effects on re-endothelialisation with Bydureon treatment add on to insulin versus insulin alone, both in combination with metformin in type 2 diabetic subjects: Rebuild study

Speaker: Doctor I. Santos-Pardo (Stockholm, SE)

Access the full session

Drug-related risk management in chronic coronary syndromes

Speakers: Doctor M. Wu, Doctor J. Shanmuganathan, Doctor Q. Ma, Professor N. Zhou, Mr F. Sousa...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by